AEZS-108 (AN-152) is a cytotoxic analog of the luteinizing hormone releasing hormone (LHRH) in which doxorubicin (DOX) is linked to the LHRH agonist D-Lys(6
PURPOSE: This study aimed to evaluate the relationship between CTC levels and prognosis in patients with smallcell lung cancer (SCLC).PATIENTS AND METHODS:
Metastasis is the most difficult aspect of cancer treatment.We have been working with natural inhibitors of metastasis, the cystatins.Cystatins are cysteine